HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
April 25, 2024 07:01 ET
|
HOOKIPA Pharma Inc.
Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligned with FDA feedback ...
Nasdaq Announces 9% Increase in Quarterly Dividend to $0.24 Per Share
April 25, 2024 07:01 ET
|
Nasdaq, Inc.
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a regular quarterly dividend of $0.24 per share on the company's outstanding common...
Fixing of coupon rates - Nykredit Realkredit A/S
April 25, 2024 07:00 ET
|
Nykredit Realkredit A/S
To Nasdaq Copenhagen 25 April 2024 FIXING OF COUPON RATES Fixing of coupon rates effective from 29 April 2024 Effective from 29 April 2024, the coupon rates of floating-rate bonds issued...
Valley National Bancorp Announces First Quarter 2024 Results
April 25, 2024 07:00 ET
|
Valley National Bank
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Valley National Bancorp (NASDAQ:VLY), the holding company for Valley National Bank, today reported net income for the first quarter 2024 of $96.3...
Why Furrever Token Reigns Supreme in 2024: Outpacing Bitcoin (BTC) Price Predictions and Ethereum (ETH) Surge
April 25, 2024 07:00 ET
|
Furrever Token
New York, NY, April 25, 2024 (GLOBE NEWSWIRE) -- The cryptocurrency market continues to experience significant developments across various dimensions. From Bitcoin's (BTC) price stagnation...
Dry Eye Treatment Devices Market to Gain 632.91 Million, by 2033 with 7.4% CAGR: States The Brainy Insights
April 25, 2024 07:00 ET
|
The Brainy Insights
Newark, April 25, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the global dry eye treatment devices market will grow from USD 309.96 Million in 2023 to USD 632.91 Million by 2033....
Brunswick Exploration Drills 58.1 Meters at 1.59% Li2O Starting From Surface at Mirage
April 25, 2024 07:00 ET
|
Brunswick Exploration
MONTREAL, April 25, 2024 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; “BRW” or the “Company”) is pleased to report the first assays from the Mirage winter drilling...
Stericycle, Inc. Reports Results For The First Quarter 2024
April 25, 2024 07:00 ET
|
Stericycle, Inc.
BANNOCKBURN, Ill., April 25, 2024 (GLOBE NEWSWIRE) -- Stericycle, Inc. (Nasdaq: SRCL) today reported results for the first quarter ended March 31, 2024. Revenues for the first quarter were...
IBN Coverage Initiated for Nutriband Inc.
April 25, 2024 07:00 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, April 25, 2024 (GLOBE NEWSWIRE) -- via IBN – Nutriband Inc. (NASDAQ: NTRB), a pharmaceutical company with a specific focus on transdermal technologies, today announces it has selected...
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
April 25, 2024 07:00 ET
|
Optinose, Inc.
YARDLEY, Pa., April 25, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...